|
RPS11 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.005000E-01 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.727400E-01 |
| Normal-vs-Stage2 |
3.773900E-02 |
| Normal-vs-Stage3 |
7.218000E-01 |
| Normal-vs-Stage4 |
5.565200E-01 |
| Stage1-vs-Stage2 |
5.589700E-02 |
| Stage1-vs-Stage3 |
3.283400E-01 |
| Stage1-vs-Stage4 |
6.260400E-01 |
| Stage2-vs-Stage3 |
3.546100E-02 |
| Stage2-vs-Stage4 |
7.679900E-02 |
| Stage3-vs-Stage4 |
7.719800E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
3.337600E-01 |
| Normal-vs-AfricanAmerican |
2.125400E-01 |
| Normal-vs-Asian |
5.553400E-01 |
| Caucasian-vs-AfricanAmerican |
3.742000E-01 |
| Caucasian-vs-Asian |
9.009200E-01 |
| AfricanAmerican-vs-Asian |
3.804200E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
6.062600E-01 |
| Normal-vs-Female |
1.449960E-01 |
| Male-vs-Female |
2.188600E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
4.706400E-01 |
| Normal-vs-Age(41-60Yrs) |
1.059990E-01 |
| Normal-vs-Age(61-80Yrs) |
2.976400E-01 |
| Normal-vs-Age(81-100Yrs) |
5.236800E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.981830E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
5.617400E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.022800E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
7.151800E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.148950E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
2.346600E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
5.111600E-01 |
| Classical-VS-Follicular |
7.841800E-02 |
| Classical-VS-Other |
3.400400E-01 |
| Classical-VS-Normal |
2.686400E-01 |
| Tall-VS-Follicular |
7.520100E-02 |
| Tall-VS-Other |
5.451400E-01 |
| Tall-VS-Normal |
6.847000E-01 |
| Follicular-VS-Other |
1.868430E-01 |
| Follicular-VS-Normal |
5.733900E-02 |
| Other-VS-Normal |
7.027400E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
3.356800E-01 |
| Normal-vs-N1 |
4.634800E-01 |
| N0-vs-N1 |
9.197600E-01 |
|
|
